Extracellular ATP formation on vascular endothelial cells is mediated by ecto‐nucleotide kinase activities via phosphotransfer reactions
The DOI matches its Crossref record.
Abstract
Cell surface ecto‐nucleotidases are considered the major effector system for inactivation of extracellular adenine nucleotides, whereas the alternative possibility of ATP synthesis has received little attention. Using a TLC assay, we investigated the main exchange activities of 3 H‐labeled adenine nucleotides on the cultured human umbilical vein endothelial cells. Stepwise nucleotide degradation to adenosine occurred when a particular nucleotide was present alone, whereas combined cell treatment with ATP and either [ 3 H]AMPor[ 3 H]ADP caused unexpected phosphory‐ lation of 3 H‐nucleotides via the backward reactions AMP → ADP → ATP. The following two groups of nucleotide‐converting ecto‐enzymes were identified based on inhibition and substrate specificity studies: 1 ) ecto‐nucleotidases, ATP‐diphosphohydrolase, and 5'‐nucleotidase; 2 ) ecto‐nucleotide kinases, adenylate kinase, and nucleoside diphosphate kinase. Ecto‐nucleo‐side diphosphate kinase possessed the highest activity, as revealed by comparative kinetic analysis, and was capable of using both adenine and nonadenine nucleotides as phosphate donors and acceptors. The transphosphorylation mechanism was confirmed by direct transfer of the γ‐phosphate from [γ‐ 32 P]ATP to AMP or nucleoside diphosphates and by measurement of extracellular ATP synthesis using luciferin‐luciferase luminometry. The data demonstrate the coexistence of opposite, ATP‐consuming and ATP‐generating, pathways on the cell surface and provide a novel mechanism for regulating the duration and magnitude of purinergic signaling in the vasculature.—Yegutkin, G. G., Henttinen, T., Jalkanen, S. Extracellular ATP formation on vascular endothelial cells is mediated by ecto‐nucleo‐tide kinase activities via phosphotransfer reactions. FASEB J. 15, 251–260 (2001)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Abbracchio, M. P., Burnstock, G., Boeynaems, J.-M., Barnard, E. A., Boyer, J. L., Kennedy, C., Knight, G. E., Fumagalli, M., Gachet, C., Jacobson, K. A., et al. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.3 · Cited by 1,281
Yegutkin, G. G. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.024 · Cited by 1,154
Self-citationBours, M. J. L., Swennen, E. L. R., Di Virgilio, F., Cronstein, B. N., & Dagnelie, P. C. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.013 · Cited by 1,030
Cellular function and molecular structure of ecto-nucleotidases
Zimmermann, H., Zebisch, M., & Sträter, N. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9309-4 · Cited by 977
Bonora, M., Patergnani, S., Rimessi, A., De Marchi, E., Suski, J. M., Bononi, A., Giorgi, C., Marchi, S., Missiroli, S., Poletti, F., et al. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9305-8 · Cited by 644
Lazarowski, E. R., Boucher, R. C., & Harden, T. K. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.4.785 · Cited by 550
Dzeja, P., & Terzic, A. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10041729 · Cited by 475
Ectonucleotidases: Some recent developments and a note on nomenclature
Zimmermann, H. (2001) · Drug Development Research · doi:10.1002/ddr.1097 · Cited by 425
Adenosine Metabolism: Emerging Concepts for Cancer Therapy
Boison, D., & Yegutkin, G. G. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.10.007 · Cited by 336
Self-citationPurinergic Signaling and Blood Vessels in Health and Disease
Burnstock, G., & Ralevic, V. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008029 · Cited by 303
Yegutkin, G. G. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2014.953627 · Cited by 299
Self-citationThe 5′-nucleotidases as regulators of nucleotide and drug metabolism
Hunsucker, S. A., Mitchell, B. S., & Spychala, J. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.01.003 · Cited by 284
Cell-surface enzymes in control of leukocyte trafficking
Salmi, M., & Jalkanen, S. (2005) · Nature Reviews Immunology · doi:10.1038/nri1705 · Cited by 281
Self-citationAlard, J.-E., Hillion, S., Guillevin, L., Saraux, A., Pers, J.-O., Youinou, P., & Jamin, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014654 · Cited by 42
“shown) suggest that hsp60/ATP synthase interactions participate also in signaling, and thereby influence ATP synthase-dependent activation and proliferation of EC [25,26].”
Background
Metadata
- Authors
- YEGUTKIN, G. G., HENTTINEN, T., & JALKANEN, S.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2001-01
- Volume
- 15
- Issue
- 1
- Pages
- 251-260
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2037093616
- Cited by
- 122
- References
- 0
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.